Clair Francomano, MD, Medical Genetics, Indianapolis, IN

ClairFrancomanoMD

Medical Genetics Indianapolis, IN

Clinical Genetics, Clinical Molecular Genetics

Professor, Medical and Molecular Genetics, Indiana University School of Medicine

Dr. Francomano is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Francomano's full profile

Already have an account?

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Medical Genetics, 1983 - 1984
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Internal Medicine, 1980 - 1983
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineClass of 1980
  • Yale UniversityB.A., Magna Cum Laude, 1976

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 2020 - Present
  • IN State Medical License
    IN State Medical License 2019 - 2021
  • MD State Medical License
    MD State Medical License 1980 - 2022
  • American Board of Internal Medicine Internal Medicine
  • American Board of Medical Genetics and Genomics Clinical Genetics
  • American Board of Medical Genetics and Genomics Clinical Molecular Genetics and Genomics

Awards, Honors, & Recognition

  • Named "Baltimore's Best" Medical Geneticist Baltimore Magazine, 2008
  • Third Annual Leaman Lectureship Cincinnati Children's Hospital Medical Center, 2003
  • Annual Award Ibero-American Society of Human Genetics, 2000
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Characteristics, Diagnosis, and Management of Ehlers-Danlos Syndromes  
    Andrew W. Joseph, Clair A. Francomano, Theda C. Kontis, JAMA
  • Transposon-mediated engineering of human primary T cells for therapy of CD19+ lymphoid malignancies  
    Huang X, Guo H, Kang J, Choi S, Zhou TC, Tammana S, Lees CJ, Li ZZ, Milone M, Levine BL, Tolar J, June CH, McIvor RS, Wagner JE, Blazar BR, Zhou X, Mol Ther, 1/1/2008
  • SEGS: Search for enriched gene sets in microarray data  
    Trajkovski I, Lavrac N, Tolar J, J Biomed Inform, 1/1/2008
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • Hematopoietic cell transplantation (HCT) for recessive dystrophic epidermolysis bullosa (RDEB): reduced intensity conditioning (RIC) has a better outcome than myeloabl...
    Tolar J, McGrath JA, Osborn MJ, Keene DR, Hook K, Hordinsky M, Woodley D, Chen M, Hovnanian A, Tamai K, Blazar BR, Wagner JE, Society for Investigative Dermatology Annual Meeting, Atlanta, GA, 1/1/2015
  • Lysyl hydroxylase 3 localizes to epidermal basement membrane and is reduced in patients with recessive dystrophic epidermolysis bullosa.
    Watt S, Dayal J, Wright S, Pourreyron C, McMillan J, Riddle M, McLean I, Leigh I, McGrath J, Salas-Alanis J, Tolar J, South AP, Society for Investigative Dermatology Annual Meeting, Atlanta, GA, 1/1/2015
  • Hepatobiliary disease in hematopoietic stem cell transplantation patients.
    Skube M, Tolar J, Schwarzenberg S, DeFor T, Acton R, Hess D, Segura B, Saltzman D, American Pediatric Surgical Association Annual Meeting, Fort Lauderdale, FL, 1/1/2015
  • Join now to see all

Lectures

  • From Marrow to Matrix 
    Indiana University, Indianapolis, IN - 1/8/2015
  • Blood and Marrow Transplantation for Severe EB 
    Nashville, TN - 1/30/2014
  • The Creative Destruction of Genes 
    University of Minnesota - 1/29/2014
  • Join now to see all

Other

  • Management of laryngeal paralysis. (2 – 60-minute Tapes) 
    Cummings CW, Costin R, Myers EA, and Ward P, AAO
    1/1/1983

Press Mentions

  • Ehlers-Danlos Syndrome Expert Available to Comment on Under-Recognized Condition
    Ehlers-Danlos Syndrome Expert Available to Comment on Under-Recognized ConditionNovember 4th, 2019
  • The Ehlers-Danlos Society Center Opens at Indiana University Health
    The Ehlers-Danlos Society Center Opens at Indiana University HealthOctober 7th, 2019
  • The Ehlers-Danlos Society Announces Worldwide Research Study to Identify the Genetic Cause of Hypermobile Ehlers-Danlos Syndrome
    The Ehlers-Danlos Society Announces Worldwide Research Study to Identify the Genetic Cause of Hypermobile Ehlers-Danlos SyndromeMarch 8th, 2019
  • Join now to see all